Page last updated: 2024-10-16

adenine and Neoplasms

adenine has been researched along with Neoplasms in 167 studies

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"The therapeutic potential of the antiretroviral drug 9-(2-phosphonylmethoxyethyl)adenine (PMEA, adefovir) for the treatment of human immunodeficiency virus (HIV)- and human hepatitis B virus (HBV) infections is currently being explored in advanced clinical trials."3.70Mechanistic study on the cytostatic and tumor cell differentiation-inducing properties of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, adefovir)-collected publications. ( Hatse, S, 2000)
" A traditional 3 + 3 dose escalation design with 5 dosing cohorts was used."3.11Phase I dose escalation study of dual PI3K/mTOR inhibition by Sapanisertib and Serabelisib in combination with paclitaxel in patients with advanced solid tumors. ( Meissner, T; Rojas-Espaillat, L; Starks, DC; Williams, CB, 2022)
" In addition to determining the MTD, we evaluated pharmacokinetics of BIIB021 and pharmacodynamic effects of BIIB021 [Hsp70, HER2 extracellular domain (HER2-ECD)]."2.79A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors. ( Banerji, U; Castro, J; Lamanna, N; Mita, M; O'Brien, S; Saif, MW; Stogard, C; Takimoto, C; Von Hoff, D, 2014)
"These cancers are potential targets for selective chemotherapy with inhibitors of de novo adenine synthesis such as L-alanosine [L-2-amino-3-(N-hydroxy-N-nitrosamino) propionic acid]."2.74A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer. ( Burris, HA; Kindler, HL; Oliff, IA; Sandler, AB, 2009)
"The outbreak of the novel coronavirus disease 2019 (COVID-19) has emerged as one of the biggest global health threats worldwide."2.72Relevance of the Bruton Tyrosine Kinase as a Target for COVID-19 Therapy. ( Macip, S; Massip-Salcedo, M; Qusairy, Z; Rada, M, 2021)
" Furthermore, the nanoformulations studied to increase ibrutinib bioavailability are reported."2.72Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective. ( Brullo, C; Russo, E; Spallarossa, A; Tasso, B; Villa, C, 2021)
"Amonafide (A) demonstrates dose-related increases in area under the curve (AUC) and Cmax values."2.68Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients. ( Akerman, S; Allen, SL; Budman, DR; Calabro, A; Chan, K; Fusco, D; Hock, K; Kreis, W; Mittelman, A; Puccio, C; Spigelman, M, 1996)
"Twenty-six patients with advanced cancer underwent acetylator phenotyping with caffeine and were assigned to a dose level."2.67Phase I study of amonafide dosing based on acetylator phenotype. ( Berezin, F; Janisch, L; Lane, LB; Mick, R; Ratain, MJ; Schilsky, RL; Vogelzang, NJ, 1993)
"EMT is involved in tumor metastasis because it leads to cancer cell migration and invasion, and is also associated with chemoresistance."2.66Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis. ( Bera, A; Lewis, SM, 2020)
"Cell purine metabolism is an important drug target."2.61Purine auxotrophy: Possible applications beyond genetic marker. ( Kokina, A; Liepins, J; Ozolina, Z, 2019)
"However, in the stratified analysis of cancer type, the significant results were only found in lung cancer (dominant model: OR = 0."2.55Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies. ( Cen, H; Pan, FZ; Shi, C; Wang, MY; Yang, WJ, 2017)
"Hsp90 allows cancer cells to tolerate the many components of dysregulated pathways in a transformation-specific manner by interacting with several client substrates, such as kinases, hormone receptors and transcription factors that are directly involved in driving multistep malignancy, and also with mutated oncogenic proteins required for the transformed phenotype."2.43Discovery and development of purine-scaffold Hsp90 inhibitors. ( Chiosis, G, 2006)
"HBsAg-positive cancer patients treated with ETV (n = 582), TDF (n = 200) and TAF (n = 188) during chemotherapy were retrospectively enrolled."1.72Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy. ( Chao, Y; Hou, MC; Huang, YH; Lan, KH; Lee, IC; Li, CP; Lin, HC; Su, CW, 2022)
"The B-cell neoplasm could not be further subclassified due to the lack of BCL2-IgH and BCL1-IgH rearrangement and morphology."1.62[Small B-cell neoplasm responding to ibrutinib after 17 years of cold agglutinin disease symptom]. ( Haga, H; Hishizawa, M; Hori, T; Iga, Y; Kondo, T; Masuda, K; Morimoto, S; Morita, M; Shindo, T; Takaori-Kondo, A; Yamashita, K; Yurugi, K, 2021)
" This study assessed the in vitro and in vivo functionality of CAR T cells transduced to express the anti-CD19 CAR of liso-cel in combination with ibrutinib or acalabrutinib."1.56Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib. ( Baturevych, A; Clouser, CR; Hause, RJ; Johnstone, TG; Jones, JC; Krejsa, CM; Ponce, R; Ports, MO; Qin, JS; Ragan, SP; Salmon, RA, 2020)
" In addition, CQ, Ku, and Rap in combination with RL2 decreased activity of lysosomal protease Cathepsin D."1.51Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors. ( Bagamanshina, AV; Kähne, T; Kit, YY; Koval, OA; Kuligina, EV; Lavrik, IN; Nushtaeva, AA; Richter, M; Richter, VA; Starykovych, MO; Troitskaya, OS; Wohlfromm, F; Yunusova, AY, 2019)
"We found that poor breast cancer patient survival was significantly associated with low TTP/HuR mRNA ratios and correlated with high levels of the mitotic ARE-mRNA signature."1.43Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins. ( Al-Ghamdi, M; Al-Saif, M; Al-Souhibani, N; Al-Yahya, S; Bakheet, T; Grépin, R; Győrffy, B; Hitti, E; Khabar, KS; Lánczky, A; Moghrabi, W; Pagès, G; Shoukri, MM, 2016)
"Numerous cancer types exhibit high inter- and intratumor heterogeneity of H1."1.43The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. ( Ben-Hamo, R; Biran, A; Burney, MJ; Chakravarty, P; Cohen, AS; Efroni, S; Henser-Brownhill, T; Li, Y; Matthews, N; Meshorer, E; Misteli, T; Nye, E; Patel, H; Scaffidi, P; Spencer-Dene, B; Torres, CM, 2016)
"This cleansing function is required for cancer cell survival and to modulate Escherichia coli antibiotic sensitivity in a DNA polymerase (pol)-dependent manner."1.42Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide. ( Beard, WA; Freudenthal, BD; Kim, T; Perera, L; Schlick, T; Shock, DD; Wilson, SH, 2015)
"This study aims to evaluate the anti-cancer effect of daucosterol and explore its possible mechanism."1.42Daucosterol inhibits cancer cell proliferation by inducing autophagy through reactive oxygen species-dependent manner. ( Cai, S; Gao, Y; Qu, L; She, T; Shou, C; Su, Y; Wang, L; Xu, S; Zhao, C, 2015)
"Concentrations achieved in vivo in tumors lead to single-agent anti-tumor activity at non-toxic doses."1.32Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90. ( Basso, A; Chiosis, G; He, H; Huezo, H; Lucas, B; Modrich, P; Rosen, N; Solit, D; Spampinato, C; Vilenchik, M, 2004)
"Kinetin riboside was shown to only act on M4 Beu human and B16 murine melanoma cells at low concentration (1."1.32Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells. ( Bos, R; Griffaut, B; Ledoigt, G; Madelmont, JC; Maurizis, JC, 2004)
"The azonafides are a series of anthracene-based DNA intercalators which inhibit tumor cell growth in vitro at low nanomolar concentrations and are not affected by the multidrug resistance phenomenon (MDR)."1.31Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators. ( Alberts, DS; Dorr, RT; Hersh, EM; Liddil, JD; Remers, W; Sami, SM, 2001)
"The effects of cancer procoagulant (CP), cysteine protease (EC 3."1.31Cancer procoagulant and blood platelet activation. ( Mielicki, WP; Olas, B; Wachowicz, B, 2001)
"All patients had a family history of tumors previously associated with A-T heterozygosity or homozygosity."1.29ATM mutations in cancer families. ( Croce, CM; Hammarström, L; Lindblom, A; Luo, L; Negrini, M; Vorechovský, I; Webster, AD, 1996)
" The drug was found to be toxic to all of the cell lines tested."1.27Studies on the mechanism of cytotoxicity of 3-deazaguanosine in human cancer cells. ( Jacobsen, SJ; Mangum, JH; Nyhan, WL; Page, T; Robins, RK; Scheele, J; Smejkal, RM, 1985)

Research

Studies (167)

TimeframeStudies, this research(%)All Research%
pre-199052 (31.14)18.7374
1990's6 (3.59)18.2507
2000's25 (14.97)29.6817
2010's58 (34.73)24.3611
2020's26 (15.57)2.80

Authors

AuthorsStudies
Lin, R1
Elf, S1
Shan, C1
Kang, HB1
Ji, Q1
Zhou, L3
Hitosugi, T1
Zhang, L4
Zhang, S3
Seo, JH1
Xie, J1
Tucker, M1
Gu, TL1
Sudderth, J1
Jiang, L1
Mitsche, M1
DeBerardinis, RJ1
Wu, S2
Li, Y6
Mao, H1
Chen, PR1
Wang, D3
Chen, GZ1
Hurwitz, SJ1
Lonial, S1
Arellano, ML1
Khoury, HJ1
Khuri, FR1
Lee, BH1
Lei, Q1
Brat, DJ1
Ye, K1
Boggon, TJ1
He, C3
Kang, S2
Fan, J1
Chen, J4
Wu, F2
Liu, Y11
Cheng, H2
Meng, Y1
Shi, J3
Chen, Y2
Wu, Y3
Ran, F1
Wang, C4
Xu, Z1
Zhang, Y9
Zhao, G1
Ling, Y1
Morimoto, S1
Shindo, T1
Iga, Y1
Morita, M1
Yurugi, K1
Masuda, K1
Hori, T1
Hishizawa, M1
Kondo, T1
Yamashita, K1
Haga, H1
Takaori-Kondo, A1
Guan, Q1
Lin, H1
Miao, L1
Guo, H2
Zhuo, Z1
He, J1
Starks, DC1
Rojas-Espaillat, L1
Meissner, T1
Williams, CB1
Dogan, S1
Spahiu, E1
Cilic, A1
Lee, IC1
Lan, KH1
Su, CW1
Li, CP1
Chao, Y1
Lin, HC1
Hou, MC1
Huang, YH1
Liu, X5
Chen, W2
Xu, Y2
Shen, Y2
Xu, X2
Kozmin, SG1
Rogozin, IB1
Moore, EA1
Abney, M1
Schaaper, RM1
Pavlov, YI1
Shi, X3
Zhang, D1
Li, F1
Zhang, Z3
Wang, S1
Xuan, Y1
Ping, Y1
Li, K1
Lu, L1
Xue, C1
Liu, J6
He, Y3
Zhou, J2
Xia, Z1
Dai, L1
Luo, Z1
Mao, Y1
Cai, K1
Qin, JS1
Johnstone, TG1
Baturevych, A1
Hause, RJ1
Ragan, SP1
Clouser, CR1
Jones, JC1
Ponce, R1
Krejsa, CM1
Salmon, RA1
Ports, MO1
García-Raso, A1
Terrón, A1
Ortega-Castro, J1
Barceló-Oliver, M1
Lorenzo, J1
Rodríguez-Calado, S1
Franconetti, A1
Frontera, A1
Vázquez-López, EM1
Fiol, JJ1
Krause, G1
Hassenrück, F1
Hallek, M1
Saini, N1
Sterling, JF1
Sakofsky, CJ1
Giacobone, CK1
Klimczak, LJ1
Burkholder, AB1
Malc, EP1
Mieczkowski, PA1
Gordenin, DA1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhao, Y3
Wang, J7
Huang, L3
Hu, K1
Liu, H4
Wang, H4
Guo, Z1
Song, Y2
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q5
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J4
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J2
Sun, M2
Xu, G1
Zhang, X7
Xu, N1
Wang, R1
Liu, S1
He, H2
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S2
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C2
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Hu, Z2
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y10
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X2
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Song, J2
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Zhang, H3
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y3
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L4
Hu, T1
Wang, F2
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X2
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q2
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Qiu, N1
Yin, J1
Zhang, J6
Guo, W1
Liu, M5
Liu, T2
Chen, D6
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W2
Yin, F1
van Hest, JCM1
Du, L2
Duan, W1
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z3
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q2
Lyu, HD1
Deng, L2
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M2
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N2
Li, C3
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X2
Pang, B1
Liu, Q2
Huang, Y3
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B2
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y4
Xue, H1
Zhang, W2
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X2
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L2
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X2
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X2
Peng, M1
Sun, XF1
Zhang, T2
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y2
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Baek, K1
Noblett, AD1
Ren, P1
Suggs, LJ1
Luppi, M1
Forghieri, F1
Potenza, L1
Zerbit, J1
Chevret, S1
Bernard, S1
Kroemer, M1
Ablard, C1
Harel, S1
Brice, P1
Madelaine, I1
Thieblemont, C1
Bera, A1
Lewis, SM1
Pileri, A1
Guglielmo, A1
Agostinelli, C1
Evangelista, V1
Bertuzzi, C1
Alessandrini, A1
Bruni, F1
Starace, M1
Massi, A1
Broccoli, A1
Patrizi, A1
Zinzani, PL1
Piraccini, BM1
Roussel, X1
Charollais, R1
Deconinck, E1
Daguindau, E1
Brion, A1
Ilhami, FB1
Alemayehu, YA1
Fan, WL1
Tsai, HC1
Kao, CY1
Cheng, CC1
Kong, Y1
Fan, W1
Tao, T1
Xiao, Q1
Rada, M1
Qusairy, Z1
Massip-Salcedo, M1
Macip, S1
Awan, FT2
Tong, D1
Zaha, VG1
Park, JM1
Yang, SW1
Zhuang, W1
Bera, AK1
Gurbani, D1
von Hoyningen-Huene, SJ1
Sakurada, SM1
Gan, H1
Pruett-Miller, SM1
Westover, KD1
Potts, MB1
Brullo, C1
Villa, C1
Tasso, B1
Russo, E1
Spallarossa, A1
Yan, L1
Xuan, C1
Molina-Cerrillo, J1
Alonso-Gordoa, T1
Gajate, P1
Grande, E1
Yang, WJ1
Wang, MY1
Pan, FZ1
Shi, C2
Cen, H1
Zahid, OK1
Swain, BE1
Parsonage, D1
Hollis, T1
Harvey, S1
Perrino, FW1
Kohli, RM1
Taylor, EW1
Hall, AR1
Rauf, F1
Festa, F1
Park, JG1
Magee, M1
Eaton, S1
Rinaldi, C1
Betanzos, CM1
Gonzalez-Malerva, L1
LaBaer, J1
Chiu, JF1
Deng, Y2
Li, G1
Zhan, Q1
Wei, S1
Lentz, R1
Feinglass, J1
Ma, S1
Akhter, N1
Chiron, D1
Rogers, KA1
Mousa, L1
Zhao, Q1
Bhat, SA1
Byrd, JC1
El Boghdadly, Z1
Guerrero, T1
Levine, LB1
Lucas, F1
Shindiapina, P1
Sigmund, AM1
Sullivan, M1
Wiczer, TE1
Woyach, JA1
Qiu, Q1
Shi, T1
Hu, L1
Zheng, H1
Chen, G1
Alderman, MH1
Xiao, AZ1
Levêque, D1
Hong, D1
Rasco, D1
Veeder, M1
Luke, JJ1
Chandler, J1
Balmanoukian, A1
George, TJ1
Munster, P1
Berlin, JD1
Gutierrez, M1
Mita, A1
Wakelee, H1
Samakoglu, S1
Guan, S1
Dimery, I1
Graef, T1
Borazanci, E1
Castelli, R1
Schiavon, R1
Preti, C1
Deliliers, GL1
Cheng, C1
Sun, S1
Mei, L1
Bagamanshina, AV1
Troitskaya, OS1
Nushtaeva, AA1
Yunusova, AY1
Starykovych, MO1
Kuligina, EV1
Kit, YY1
Richter, M1
Wohlfromm, F1
Kähne, T1
Lavrik, IN1
Richter, VA1
Koval, OA1
Kokina, A1
Ozolina, Z1
Liepins, J1
Saif, MW1
Takimoto, C1
Mita, M2
Banerji, U1
Lamanna, N1
Castro, J1
O'Brien, S1
Stogard, C1
Von Hoff, D1
Neckers, L1
Trepel, JB1
Lee, JW1
Kim, KS1
An, HK1
Kim, CH1
Moon, HI1
Lee, YC1
Adlard, AL1
Dovedi, SJ1
Telfer, BA1
Koga-Yamakawa, E1
Pollard, C1
Honeychurch, J1
Illidge, TM1
Murata, M1
Robinson, DT1
Jewsbury, PJ1
Wilkinson, RW1
Stratford, IJ1
Jangir, DK1
Mehrotra, R1
Xing, L1
Huang, A1
Davids, MS1
Brown, JR1
Boele, J1
Persson, H1
Shin, JW1
Ishizu, Y1
Newie, IS1
Søkilde, R1
Hawkins, SM1
Coarfa, C1
Ikeda, K1
Takayama, K1
Horie-Inoue, K1
Ando, Y1
Burroughs, AM1
Sasaki, C1
Suzuki, C1
Sakai, M1
Aoki, S1
Ogawa, A1
Hasegawa, A1
Lizio, M1
Kaida, K1
Teusink, B1
Carninci, P1
Suzuki, H1
Inoue, S1
Gunaratne, PH1
Rovira, C1
Hayashizaki, Y1
de Hoon, MJ1
Freudenthal, BD1
Beard, WA1
Perera, L1
Shock, DD1
Kim, T1
Schlick, T1
Wilson, SH1
Ho, EY1
Yau, T1
Rousseau, F1
Heathcote, EJ1
Lau, GK1
Tang, X1
Xu, R1
Hu, G1
Rao, H1
Luo, S1
Lu, Q1
Chandra, G1
Moon, YW1
Lee, Y1
Jang, JY1
Nayak, A1
Oh, K1
Mulamoottil, VA1
Sahu, PK1
Kim, G1
Chang, TS1
Noh, M1
Lee, SK1
Choi, S1
Jeong, LS1
Sachdev, E1
Gong, J1
Rimel, B1
Zhao, C1
She, T1
Su, Y1
Qu, L1
Xu, S1
Shou, C1
Evans, GB1
Cameron, SA1
Luxenburger, A1
Guan, R1
Suarez, J1
Thomas, K1
Schramm, VL1
Tyler, PC1
Kokhaei, P1
Jadidi-Niaragh, F1
Sotoodeh Jahromi, A1
Osterborg, A1
Mellstedt, H1
Hojjat-Farsangi, M1
Hawkes, N1
Koehler, M1
Donnelly, ET1
Kalanovic, D1
Dagher, R1
Rothenberg, ML1
Hitti, E1
Bakheet, T1
Al-Souhibani, N1
Moghrabi, W1
Al-Yahya, S1
Al-Ghamdi, M1
Al-Saif, M1
Shoukri, MM1
Lánczky, A1
Grépin, R1
Győrffy, B1
Pagès, G1
Khabar, KS1
de Jong, J1
Skee, D1
Hellemans, P1
de Vries, R1
Swerts, D1
Lawitz, E1
Marbury, T1
Smith, W1
Sukbuntherng, J1
Mannaert, E1
Liang, D1
Song, W1
Zhai, S1
Zhang, LH1
Ye, M1
Torres, CM1
Biran, A1
Burney, MJ1
Patel, H1
Henser-Brownhill, T1
Cohen, AS1
Ben-Hamo, R1
Nye, E1
Spencer-Dene, B1
Chakravarty, P1
Efroni, S1
Matthews, N1
Misteli, T1
Meshorer, E1
Scaffidi, P1
Li, M2
Xie, S1
Patel, A1
Wang, YJ1
Zhang, YK1
Kathawala, RJ1
Qiu, LH1
Patel, BA1
Huang, LH1
Shukla, S1
Yang, DH1
Ambudkar, SV1
Fu, LW1
Chen, ZS1
Kindler, HL1
Burris, HA1
Sandler, AB1
Oliff, IA1
Oh, SH1
Kim, YS1
Lim, SC1
Hou, YF1
Chang, IY1
You, HJ1
Tafani, M2
Schito, L2
Anwar, T1
Indelicato, M2
Sale, P1
Di Vito, M1
Morgante, E1
Beraldi, R1
Makovec, F1
Letari, O1
Caselli, G1
Spadafora, C1
Pucci, B2
Russo, MA2
Lubin, M1
Lubin, A1
Wilson, WR1
Stribbling, SM1
Pruijn, FB1
Syddall, SP1
Patterson, AV1
Liyanage, HD1
Smith, E1
Botting, KJ1
Tercel, M1
Reali, V1
Aventaggiato, M1
Mazzarino, MC1
Stivala, F1
Fini, M1
Knight, ZA1
Hillmann, P1
Hofmann, BT1
Hart, JR1
Vogt, PK1
Wang, GT1
Mantei, RA1
Hubbard, RD1
Wilsbacher, JL1
Tucker, L1
Hu, X1
Kovar, P1
Johnson, EF1
Osterling, DJ1
Bouska, J1
Davidsen, SK1
Bell, RL1
Sheppard, GS1
Riahi, S1
Eynollahi, S1
Ganjali, MR1
Luo, HM1
Yin, JY1
Yang, XH1
Mikulski, D1
Szeląg, M1
Molski, M1
Kuwahara, Y1
Oikawa, T1
Ochiai, Y1
Roudkenar, MH1
Fukumoto, M2
Shimura, T1
Ohtake, Y1
Ohkubo, Y1
Mori, S1
Uchiyama, Y1
Tardif, KD1
Rogers, A1
Cassiano, J1
Roth, BL1
Cimbora, DM1
McKinnon, R1
Peterson, A1
Douce, TB1
Robinson, R1
Dorweiler, I1
Davis, T1
Hess, MA1
Ostanin, K1
Papac, DI1
Baichwal, V1
McAlexander, I1
Willardsen, JA1
Saunders, M1
Christophe, H1
Kumar, DV1
Wettstein, DA1
Carlson, RO1
Williams, BL1
Hou, H1
Yi, Q1
Lv, L1
Hao, Q1
Shi, Q1
Driscoll, JJ1
Chowdhury, RD1
Sidera, K1
Patsavoudi, E1
Kast, RE1
GRIFFIN, AC3
DAVIS, WE2
TIFFT, MO1
WAY, JL1
MANDEL, HG1
SMITH, PK1
BARCLAY, RK1
GARFINKEL, E1
FURLONG, NB2
WATSON, EJ1
WANIA, AF1
LEDOUX, L1
BALTUS, E1
VANDERHAEGHE, F1
HORNSEY, S1
HOWARD, A1
FJELDE, A2
ALBAUM, HG1
ZAHL, PA1
ROGERS, S1
PAOLINO, W1
PIERRI, G1
VERCELLINO, E1
FORSSBERG, A1
FINLAYSON, JS1
DREYFUS, G1
HENDERSON, JF3
JUNGA, IG3
VARDANIS, A1
HOCHSTER, RM1
WRBA, H1
GEIPEL, A1
JACQUEZ, JA1
GINSBERG, F1
BALIS, ME1
PECORA, P1
SALSER, JS1
SARTORELLI, AC1
UPCHURCH, HF1
NEOGY, RK1
BOSE, S1
HAREL, J1
HAREL, L1
LACOUR, F1
BOER, A1
IMBENOTTE, J1
COSTAKEL, O1
CLARK, JB1
GREENBAUM, AL1
MCLEAN, P1
REID, E1
CAMBRIA, A1
LOMBARDO, N1
GIUFFRIDA, AM1
BENNETT, LL1
SMITHERS, D1
WARD, CT1
WOOLFREY, BF1
BRAGONIER, JR1
ROESKY, N1
CARVER, MJ1
LEPAGE, GA3
RABOTTI, G1
MANOILOV, SE1
KITAVIN, GS1
COMAR, VE1
ORLOVA, EU1
SHIGEURA, HT1
GORDON, CN1
SATO, K1
ELLIS, DB1
OKAMURA, N1
BUSCH, H1
HARTUNG, EW1
KLENOW, H1
Woynarowski, JM1
Vilenchik, M1
Solit, D1
Basso, A1
Huezo, H1
Lucas, B1
Rosen, N1
Spampinato, C1
Modrich, P1
Chiosis, G2
Avila, MA1
García-Trevijano, ER1
Lu, SC1
Corrales, FJ1
Mato, JM1
Griffaut, B1
Bos, R1
Maurizis, JC1
Madelmont, JC1
Ledoigt, G1
MUELLER, GC1
MILLER, JA1
Budiman, ME1
Bierbach, U2
Alexander, RW1
Silamkoti, AV1
Allan, PW1
Hassan, AE1
Fowler, AT1
Sorscher, EJ1
Parker, WB1
Secrist, JA1
Dalgarno, D1
Stehle, T1
Narula, S1
Schelling, P1
van Schravendijk, MR1
Adams, S1
Andrade, L1
Keats, J1
Ram, M1
Jin, L1
Grossman, T1
MacNeil, I1
Metcalf, C1
Shakespeare, W1
Keenan, T1
Sundaramoorthi, R1
Bohacek, R1
Weigele, M1
Sawyer, T1
Shinohara, K1
Bando, T1
Sasaki, S1
Sakakibara, Y1
Minoshima, M1
Sugiyama, H1
Saeed, M1
Higginbotham, S1
Rogan, E1
Cavalieri, E1
Guddneppanavar, R1
Li, YL1
Torchet, C1
Vergne, J1
Maurel, MC1
Nair, U1
Bartsch, H2
Nair, J1
Ropolo, A1
Grasso, D1
Pardo, R1
Sacchetti, ML1
Archange, C1
Lo Re, A1
Seux, M1
Nowak, J1
Gonzalez, CD1
Iovanna, JL1
Vaccaro, MI1
Choudhury, S1
Adhikari, S1
Cheema, A1
Roy, R1
Huennekens, FM1
Suresh, MR1
Vitols, KS1
Henderson, GB1
Ratain, MJ1
Mick, R1
Berezin, F1
Janisch, L1
Schilsky, RL1
Vogelzang, NJ1
Lane, LB1
Kreis, W1
Chan, K1
Budman, DR1
Allen, SL1
Fusco, D1
Mittelman, A1
Hock, K1
Akerman, S1
Calabro, A1
Puccio, C1
Spigelman, M1
Vorechovský, I1
Lindblom, A1
Negrini, M1
Webster, AD1
Croce, CM1
Hammarström, L1
Hatse, S1
Dorr, RT1
Liddil, JD1
Sami, SM1
Remers, W1
Hersh, EM1
Alberts, DS1
Olas, B1
Wachowicz, B1
Mielicki, WP1
de Kreuk, AM1
Jonkhoff, AR1
Zevenbergen, A1
Hendriks, EC1
Schuurhuis, GJ1
Ossenkoppele, GJ1
Dräger, AM1
van Oostveen, JW1
Huijgens, PC1
Lakings, DR1
Gehrke, CW1
Waalkes, TP2
Lakings, DB1
Mrochek, JE1
Schöch, G1
Winkler, K1
Heller-Schöch, G1
Baisch, H1
Fuska, J1
Proksa, B1
Fusková, A1
Kaneko, K1
Fujimori, S1
Kumakawa, T1
Kamatani, N1
Akaoka, I1
Stagg, MP1
Diasio, RB1
Ohshima, H1
Shuker, DE1
Pignatelli, B1
Calmels, S1
Mishra, PC1
Page, T1
Jacobsen, SJ1
Smejkal, RM1
Scheele, J1
Nyhan, WL1
Mangum, JH1
Robins, RK1
Marquardt, H1
Zimmermann, FK1
Dannenberg, H1
Neumann, HG1
Bodenberger, A1
Metzler, M1
Sugiura, K1
Brown, GB1
Shapot, VS1
Vornovitskaya, GI1
Gorozhanskaya, EG1
Davidova, SY1
Zhubanova, AA1
Krechetova, GD1
Chudinova, IA1
Paterson, AR1
Caldwell, IC1
Paul, B1
Chan, MC1
Lau, KF1
Sims, L1
Mirvish, SS1
Medalie, J1
Linsell, CA1
Yousuf, E1
Reyad, S1
Rotherham, J1
Price, FM1
Otani, TT1
Evans, VJ1
Wheeler, GP1
Alexander, JA1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1 Evaluation of the Safety and Tolerability of TAK-228 in Combination With TAK-117 and Paclitaxel in Advanced Solid Tumors[NCT03154294]Phase 130 participants (Anticipated)Interventional2017-07-06Active, not recruiting
A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of BIIB021 Administered Once or Twice Daily to Subjects With Advanced Solid Tumors[NCT00618735]Phase 168 participants (Actual)Interventional2008-02-29Completed
An Open-Label, Multicenter, Pharmacokinetic Study of PCI-32765 in Subjects With Varying Degrees of Hepatic Impairment[NCT01767948]Phase 130 participants (Actual)Interventional2012-12-31Completed
Phase I Dose-escalation, Pharmacokinetic and Pharmacodynamic Study of Debio 0932, a Novel Hsp90-inhibitor, Administered Orally, in Patients With Advanced Solid Tumours or Lymphoma[NCT01168752]Phase 181 participants (Actual)Interventional2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

29 reviews available for adenine and Neoplasms

ArticleYear
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms;

2015
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; B-Lymphocytes; Cyclin-Dependent Kinase 4; Drug Resista

2022
Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.
    Journal of hematology & oncology, 2022, 02-03, Volume: 15, Issue:1

    Topics: Adenine; Animals; Carcinogenesis; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methy

2022
Targeting IGF2BP3 in Cancer.
    International journal of molecular sciences, 2023, May-29, Volume: 24, Issue:11

    Topics: Adenine; Adenosine; Eukaryota; Humans; Neoplasms; RNA

2023
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Regulation of Epithelial-to-Mesenchymal Transition by Alternative Translation Initiation Mechanisms and Its Implications for Cancer Metastasis.
    International journal of molecular sciences, 2020, Jun-07, Volume: 21, Issue:11

    Topics: Adenine; Animals; Disease Progression; Epithelial-Mesenchymal Transition; Humans; Models, Biological

2020
Principles of RNA methylation and their implications for biology and medicine.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131

    Topics: Adenine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Hu

2020
Relevance of the Bruton Tyrosine Kinase as a Target for COVID-19 Therapy.
    Molecular cancer research : MCR, 2021, Volume: 19, Issue:4

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antiviral Agents; Benzamides; COVID-19; COVID-19 Drug

2021
Btk Inhibitors: A Medicinal Chemistry and Drug Delivery Perspective.
    International journal of molecular sciences, 2021, Jul-16, Volume: 22, Issue:14

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Chemistry, Pharmaceutical; COVID-19 Drug Treatment; Dr

2021
BIIB021: A novel inhibitor to heat shock protein 90-addicted oncology.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:4

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; HSP90 Heat-Shock Proteins; Humans; Mice; Neoplas

2017
Bruton's tyrosine kinase (BTK) as a promising target in solid tumors.
    Cancer treatment reviews, 2017, Volume: 58

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Humans; Neoplasms; Pip

2017
Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
    World journal of surgical oncology, 2017, Aug-02, Volume: 15, Issue:1

    Topics: Adenine; Asian People; Gene Frequency; Genetic Predisposition to Disease; Genotype; Guanine; Humans;

2017
N(6)-Methyladenine in eukaryotes.
    Cellular and molecular life sciences : CMLS, 2019, Volume: 76, Issue:15

    Topics: Adenine; Animals; DNA Methylation; DNA Repair Enzymes; Epigenomics; Eukaryota; Humans; Neoplasms; Ox

2019
Purine auxotrophy: Possible applications beyond genetic marker.
    Yeast (Chichester, England), 2019, Volume: 36, Issue:11

    Topics: Adenine; Cell Cycle Checkpoints; Drug Development; Eukaryota; Humans; Neoplasms; Purines; Saccharomy

2019
Bruton's TK inhibitors: structural insights and evolution of clinical candidates.
    Future medicinal chemistry, 2014, Volume: 6, Issue:6

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Autoimmune Diseases; Clinical Trials as Topic

2014
Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase.
    Future oncology (London, England), 2014, Volume: 10, Issue:6

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; Antineoplastic Combine

2014
Ibrutinib-A double-edge sword in cancer and autoimmune disorders.
    Journal of drug targeting, 2016, Volume: 24, Issue:5

    Topics: Adenine; Animals; Autoimmune Diseases; Humans; Immunologic Factors; Neoplasms; Piperidines; Protein-

2016
Small molecule inhibitors of the PI3-kinase family.
    Current topics in microbiology and immunology, 2010, Volume: 347

    Topics: Adenine; Androstadienes; Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Chrom

2010
[Progress in the study of heat shock protein 90 inhibitors].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:7

    Topics: Adenine; Animals; Anisoles; Antineoplastic Agents; Benzoquinones; Catechin; Cell Line, Tumor; Crysta

2010
Molecular crosstalk between the proteasome, aggresomes and autophagy: translational potential and clinical implications.
    Cancer letters, 2012, Dec-28, Volume: 325, Issue:2

    Topics: Adenine; Antineoplastic Agents; Autophagy; Boronic Acids; Bortezomib; Chloroquine; Clinical Trials a

2012
HSP90 inhibitors: current development and potential in cancer therapy.
    Recent patents on anti-cancer drug discovery, 2014, Volume: 9, Issue:1

    Topics: Adenine; Animals; Antineoplastic Agents; Benzodioxoles; Cell Membrane; Clinical Trials as Topic; Dru

2014
AT islands - their nature and potential for anticancer strategies.
    Current cancer drug targets, 2004, Volume: 4, Issue:2

    Topics: Adenine; Animals; Antineoplastic Agents; DNA Replication; DNA, Neoplasm; Drug Evaluation, Preclinica

2004
Methylthioadenosine.
    The international journal of biochemistry & cell biology, 2004, Volume: 36, Issue:11

    Topics: Adenine; Animals; Apoptosis; Cell Differentiation; Deoxyadenosines; Gene Expression Regulation; Huma

2004
Discovery and development of purine-scaffold Hsp90 inhibitors.
    Current topics in medicinal chemistry, 2006, Volume: 6, Issue:11

    Topics: Adenine; Animals; Anisoles; Antineoplastic Agents; Drug Design; HSP90 Heat-Shock Proteins; Humans; M

2006
Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores.
    Anti-cancer agents in medicinal chemistry, 2007, Volume: 7, Issue:1

    Topics: Acridines; Adenine; Animals; Antineoplastic Agents; DNA Adducts; Humans; Models, Molecular; Molecula

2007
Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.
    Free radical biology & medicine, 2007, Oct-15, Volume: 43, Issue:8

    Topics: Adenine; Animals; Biomarkers; Deoxyadenosines; Deoxyguanosine; DNA Adducts; DNA Damage; Humans; Infl

2007
Novel chemotherapeutic agents in early clinical development.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans;

1990
Exposure of humans to endogenous N-nitroso compounds: implications in cancer etiology.
    Mutation research, 1990, Volume: 238, Issue:3

    Topics: Adenine; Bacterial Infections; Esophageal Neoplasms; Gastric Mucosa; Humans; Kinetics; Methylation;

1990
Notes on some peculiarities of enzymic processes in malignant tumours and tissues of the host.
    Neoplasma, 1972, Volume: 19, Issue:4

    Topics: Adenine; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Catalase; Cholesterol; DNA, Neoplasm;

1972

Trials

10 trials available for adenine and Neoplasms

ArticleYear
Phase I dose escalation study of dual PI3K/mTOR inhibition by Sapanisertib and Serabelisib in combination with paclitaxel in patients with advanced solid tumors.
    Gynecologic oncology, 2022, Volume: 166, Issue:3

    Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; Cohort Studies; Humans; Imida

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
    Oncology, 2019, Volume: 97, Issue:2

    Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Aged, 80 and over; Antibodies, Monoclonal

2019
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-15, Volume: 20, Issue:2

    Topics: Adenine; Administration, Oral; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Fluorode

2014
Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.
    Hepatology international, 2015, Volume: 9, Issue:2

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Femal

2015
Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:1

    Topics: Adenine; Adult; Aged; Area Under Curve; Biomarkers; Drug Monitoring; Female; Humans; Incidence; Live

2017
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.
    Investigational new drugs, 2009, Volume: 27, Issue:1

    Topics: Adenine; Adolescent; Adult; Aged; Alanine; Antimetabolites, Antineoplastic; Drug Administration Sche

2009
Phase I study of amonafide dosing based on acetylator phenotype.
    Cancer research, 1993, May-15, Volume: 53, Issue:10 Suppl

    Topics: Acetylation; Adenine; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female;

1993
Clinical pharmacokinetics of amonafide (NSC 308847) in 62 patients.
    Cancer investigation, 1996, Volume: 14, Issue:4

    Topics: Adenine; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Half-Life; Hu

1996
Novel chemotherapeutic agents in early clinical development.
    Current opinion in oncology, 1990, Volume: 2, Issue:6

    Topics: Adenine; Alkaloids; Anthraquinones; Antineoplastic Agents; Biphenyl Compounds; Camptothecin; Humans;

1990

Other Studies

130 other studies available for adenine and Neoplasms

ArticleYear
Enhanced Cancer Starvation Therapy Based on Glucose Oxidase/3-Methyladenine-Loaded Dendritic Mesoporous OrganoSilicon Nanoparticles.
    Biomolecules, 2021, 09-14, Volume: 11, Issue:9

    Topics: Adenine; Animals; Cell Line, Tumor; Cell Proliferation; Dendrimers; Female; Glucose Oxidase; Humans;

2021
[Small B-cell neoplasm responding to ibrutinib after 17 years of cold agglutinin disease symptom].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2021, Volume: 62, Issue:12

    Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Female; Humans; Lymphoproliferative Disorders; Neoplas

2021
Structural Analysis of microRNAs in Myeloid Cancer Reveals Consensus Motifs.
    Genes, 2022, 06-26, Volume: 13, Issue:7

    Topics: Adenine; Base Sequence; MicroRNAs; Neoplasms; Nucleotides; Uracil

2022
Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
    Blood advances, 2022, 09-13, Volume: 6, Issue:17

    Topics: Adenine; Humans; Neoplasms; Piperidines; Pyrazoles; Pyrimidines

2022
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.
    International journal of molecular sciences, 2022, Sep-26, Volume: 23, Issue:19

    Topics: Acute Kidney Injury; Adenine; Alanine; Antiviral Agents; Cisplatin; Hepatitis B Surface Antigens; He

2022
Comment on "A commensal strain of
    Science advances, 2019, Volume: 5, Issue:9

    Topics: Adenine; Humans; Mutagenesis; Neoplasms; Saccharomyces cerevisiae; Staphylococcus epidermidis

2019
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity.
    Journal of hematology & oncology, 2019, 11-29, Volume: 12, Issue:1

    Topics: Adenine; Animals; Cytotoxicity, Immunologic; Glycosylation; Humans; Immunotherapy, Adoptive; Lymphoc

2019
Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.
    Nanoscale, 2020, Jan-07, Volume: 12, Issue:1

    Topics: Adenine; Animals; Antineoplastic Agents; Cell Line; Cell Survival; Drug Carriers; Female; Ferrosofer

2020
Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib.
    Journal of immunotherapy (Hagerstown, Md. : 1997), 2020, Volume: 43, Issue:4

    Topics: Adenine; Animals; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomar

2020
Iridium(III) coordination of N(6) modified adenine derivatives with aminoacid chains.
    Journal of inorganic biochemistry, 2020, Volume: 205

    Topics: A549 Cells; Adenine; Antineoplastic Agents; Coordination Complexes; HeLa Cells; Humans; Iridium; MCF

2020
Cell line-based assessment of BTK inhibitors.
    British journal of pharmacology, 2020, Volume: 177, Issue:9

    Topics: Adenine; B-Lymphocytes; Cell Line; Humans; Mutation; Neoplasms; Piperidines; Protein Kinase Inhibito

2020
Mutation signatures specific to DNA alkylating agents in yeast and cancers.
    Nucleic acids research, 2020, 04-17, Volume: 48, Issue:7

    Topics: Adenine; Alkylating Agents; Animals; DNA Glycosylases; DNA, Fungal; DNA, Single-Stranded; Humans; Mi

2020
Self-assembled nucleo-tripeptide hydrogels provide local and sustained doxorubicin release.
    Biomaterials science, 2020, Jun-07, Volume: 8, Issue:11

    Topics: Adenine; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems;

2020
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-15, Volume: 71, Issue:12

    Topics: Adenine; B-Lymphocytes; Consensus; Humans; Immunosuppressive Agents; Mycoses; Neoplasms; Piperidines

2020
Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study.
    Annals of hematology, 2020, Volume: 99, Issue:7

    Topics: Adenine; Aged; Aged, 80 and over; Cohort Studies; Efficiency, Organizational; Female; Humans; Male;

2020
Cutaneous adverse-events in patients treated with Ibrutinib.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Adenine; Humans; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines

2020
Pyogenic Granuloma During Ibrutinib Therapy for B-Cell Neoplasia.
    JCO oncology practice, 2020, Volume: 16, Issue:12

    Topics: Adenine; B-Lymphocytes; Granuloma, Pyogenic; Humans; Neoplasms; Piperidines; Pyrazoles

2020
Adenine-Functionalized Supramolecular Micelles for Selective Cancer Chemotherapy.
    Macromolecular bioscience, 2020, Volume: 20, Issue:12

    Topics: Adenine; Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Doxorubicin; Drug Car

2020
Cardio-Oncology: A Win-Win Situation: How Solving the Mystery of an Ibrutinib Off-Target Effect Reveals New Insights Into Atrial Fibrillation Mechanisms.
    Circulation, 2020, 12-22, Volume: 142, Issue:25

    Topics: Adenine; Atrial Fibrillation; Humans; Neoplasms; Piperidines; Pyrazoles; Pyrimidines

2020
The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.
    PLoS biology, 2021, Volume: 19, Issue:6

    Topics: Adenine; Animals; Autophagy; Beclin-1; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; En

2021
Solid-State Nanopore Analysis of Diverse DNA Base Modifications Using a Modular Enzymatic Labeling Process.
    Nano letters, 2017, 11-08, Volume: 17, Issue:11

    Topics: Adenine; Base Pair Mismatch; Biosensing Techniques; DNA; DNA Damage; DNA Repair; Epigenesis, Genetic

2017
Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner.
    Oncogene, 2018, Volume: 37, Issue:17

    Topics: A549 Cells; Adenine; Animals; Cell Proliferation; Cells, Cultured; Humans; Mice; Mice, Inbred NOD; M

2018
Resveratrol induces autophagy-dependent apoptosis in HL-60 cells.
    BMC cancer, 2018, May-22, Volume: 18, Issue:1

    Topics: Adenine; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents,

2018
Drug-Controlled Release Based on Complementary Base Pairing Rules for Photodynamic-Photothermal Synergistic Tumor Treatment.
    Small (Weinheim an der Bergstrasse, Germany), 2019, Volume: 15, Issue:3

    Topics: Adenine; Animals; Base Pairing; Cell Line, Tumor; Combined Modality Therapy; Delayed-Action Preparat

2019
Risk factors for the development of atrial fibrillation on ibrutinib treatment.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:6

    Topics: Adenine; Aged; Atrial Fibrillation; Comorbidity; Electrocardiography; Female; Heart Failure; Humans;

2019
Three targets in 1 shot against ibrutinib resistance.
    Blood, 2019, 02-28, Volume: 133, Issue:9

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Humans; Neoplasms; Piperidines; Pyrazoles; Pyrimidines

2019
Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies.
    Leukemia, 2019, Volume: 33, Issue:10

    Topics: Adenine; Adult; Aged; Aged, 80 and over; B-Lymphocytes; Female; Humans; Incidence; Male; Middle Aged

2019
Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.
    Acta biomaterialia, 2019, 07-01, Volume: 92

    Topics: Adenine; Animals; Drug Delivery Systems; Immunotherapy; Macrophages; Male; Mice; N-Acetylneuraminic

2019
[Dose reassessment: An answer to the high cost of drugs used in oncology?]
    Bulletin du cancer, 2019, Volume: 106, Issue:9

    Topics: Abiraterone Acetate; Adenine; Antineoplastic Agents; Clinical Protocols; Dasatinib; Drug Costs; Fran

2019
Ibrutinib related bleeding complications in elderly patients with B cell malignancies.
    Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:4

    Topics: Adenine; Aged; B-Lymphocytes; Hemorrhage; Humans; Neoplasms; Piperidines; Pyrazoles; Pyrimidines

2019
Intracellular Trafficking Network and Autophagy of PHBHHx Nanoparticles and their Implications for Drug Delivery.
    Scientific reports, 2019, 07-03, Volume: 9, Issue:1

    Topics: Adenine; Animals; Antineoplastic Agents, Phytogenic; Autophagy; Caveolins; Clathrin; Drug Carriers;

2019
Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.
    BioMed research international, 2019, Volume: 2019

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Caseins; Cathepsin D; Cell Death; Cel

2019
Stressing the development of small molecules targeting HSP90.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-15, Volume: 20, Issue:2

    Topics: Adenine; Antineoplastic Agents; Humans; Neoplasms; Pyridines

2014
Dendropanoxide induces autophagy through ERK1/2 activation in MG-63 human osteosarcoma cells and autophagy inhibition enhances dendropanoxide-induced apoptosis.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Adenine; Apoptosis; Autophagy; Bone Neoplasms; Cell Survival; Enzyme Activation; Humans; MAP Kinase

2013
A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models.
    International journal of cancer, 2014, Aug-15, Volume: 135, Issue:4

    Topics: Adenine; Animals; B-Lymphocytes; Disease Models, Animal; Female; HEK293 Cells; Humans; Immunotherapy

2014
Raman spectroscopic evaluation of DNA adducts of a platinum containing anticancer drug.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2014, Sep-15, Volume: 130

    Topics: Adenine; Animals; Antineoplastic Agents; Carboplatin; Cattle; Cisplatin; Cross-Linking Reagents; DNA

2014
PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Aug-05, Volume: 111, Issue:31

    Topics: Adenine; Base Sequence; Cytosine; Exoribonucleases; Gene Expression Profiling; Gene Expression Regul

2014
Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide.
    Nature, 2015, Jan-29, Volume: 517, Issue:7536

    Topics: Adenine; Base Pairing; Catalytic Domain; Crystallography, X-Ray; Cytosine; Cytotoxins; Deoxyguanine

2015
Inhibition of Hedgehog signaling pathway impedes cancer cell proliferation by promotion of autophagy.
    European journal of cell biology, 2015, Volume: 94, Issue:5

    Topics: Adenine; Autophagy; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Hedgehog Proteins; Humans

2015
Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities.
    Journal of medicinal chemistry, 2015, Jun-25, Volume: 58, Issue:12

    Topics: Adenine; Adenosine; Adenosylhomocysteinase; Animals; Antineoplastic Agents; Antiviral Agents; Cell L

2015
Adnectin-targeted inhibitors: rationale and results.
    Current oncology reports, 2015, Volume: 17, Issue:8

    Topics: Adenine; Angiogenesis Inhibitors; Antineoplastic Agents; Bortezomib; Clinical Trials as Topic; Drug

2015
Daucosterol inhibits cancer cell proliferation by inducing autophagy through reactive oxygen species-dependent manner.
    Life sciences, 2015, Sep-15, Volume: 137

    Topics: Acetylcysteine; Adenine; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cel

2015
Tight binding enantiomers of pre-clinical drug candidates.
    Bioorganic & medicinal chemistry, 2015, Sep-01, Volume: 23, Issue:17

    Topics: Adenine; Drug Discovery; Escherichia coli; Humans; Models, Molecular; Neoplasms; Plasmodium falcipar

2015
Five cancer drugs back on NHS list after deals with drug companies.
    BMJ (Clinical research ed.), 2015, Nov-05, Volume: 351

    Topics: Adenine; Aniline Compounds; Antineoplastic Agents; Bevacizumab; Brentuximab Vedotin; Cost-Benefit An

2015
Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:7

    Topics: Adenine; Antineoplastic Agents; Drug Evaluation; Humans; Neoplasms; Patient Selection; Piperazines;

2016
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.
    Cancer research, 2016, 07-15, Volume: 76, Issue:14

    Topics: Adenine; Cell Cycle Checkpoints; Cell Line, Tumor; ELAV-Like Protein 1; Gene Expression Regulation,

2016
The decreased N
    Biochemical and biophysical research communications, 2016, Nov-04, Volume: 480, Issue:1

    Topics: 3T3-L1 Cells; 5-Methylcytosine; Adenine; Animals; Chromatography, High Pressure Liquid; DNA; Gene Ex

2016
The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity.
    Science (New York, N.Y.), 2016, 09-30, Volume: 353, Issue:6307

    Topics: Adenine; Cell Line, Tumor; DNA; DNA Methylation; Enhancer Elements, Genetic; Epigenesis, Genetic; Ge

2016
Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
    Chemical biology & drug design, 2017, Volume: 89, Issue:5

    Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug S

2017
The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
    Molecular cancer therapeutics, 2017, Volume: 16, Issue:6

    Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; ATP Binding Cassette T

2017
Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner.
    Autophagy, 2008, Volume: 4, Issue:8

    Topics: Adenine; Amitrole; Apoptosis; Autophagy; Autophagy-Related Protein 5; Capsaicin; Caspase 3; Catalase

2008
Induction of autophagic cell death by a novel molecule is increased by hypoxia.
    Autophagy, 2008, Volume: 4, Issue:8

    Topics: Adenine; Amidines; Androstadienes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic

2008
Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
    PloS one, 2009, May-29, Volume: 4, Issue:5

    Topics: Adenine; Cell Death; Cell Line; Coculture Techniques; Deoxyadenosines; Drug Screening Assays, Antitu

2009
Nitro-chloromethylbenzindolines: hypoxia-activated prodrugs of potent adenine N3 DNA minor groove alkylators.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:10

    Topics: Adenine; Alkylating Agents; Alkylation; Animals; Antineoplastic Agents; Bystander Effect; Cell Cultu

2009
Role of hypoxia and autophagy in MDA-MB-231 invasiveness.
    Journal of cellular physiology, 2010, Volume: 223, Issue:2

    Topics: Adenine; Autophagy; Cell Hypoxia; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cell Survi

2010
Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
    Proceedings of the National Academy of Sciences of the United States of America, 2010, Aug-31, Volume: 107, Issue:35

    Topics: Adenine; Amino Acid Sequence; Animals; Base Sequence; Blotting, Western; Catalytic Domain; Cell Line

2010
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases.
    Bioorganic & medicinal chemistry letters, 2010, Oct-15, Volume: 20, Issue:20

    Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Human

2010
Computational studies on effects of MDMA as an anticancer drug on DNA.
    Chemical biology & drug design, 2010, Volume: 76, Issue:5

    Topics: Adenine; Antineoplastic Agents; Base Pairing; Cytosine; DNA; Drug Design; Guanine; Humans; Intercala

2010
Quantum-chemical study of interactions of trans-resveratrol with guanine-thymine dinucleotide and DNA-nucleobases.
    Journal of molecular modeling, 2011, Volume: 17, Issue:12

    Topics: Adenine; Antineoplastic Agents, Phytogenic; Cytosine; DNA; DNA Breaks; Guanine; Humans; Hydrogen Bon

2011
Enhancement of autophagy is a potential modality for tumors refractory to radiotherapy.
    Cell death & disease, 2011, Jun-30, Volume: 2

    Topics: Adenine; Autophagy; Cell Death; Cell Survival; Humans; Neoplasms; Radiation Tolerance; Tumor Cells,

2011
Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:12

    Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; HCT116 Cells; Humans; Mice; Mice, Nude; M

2011
Inhibitors of phosphatidylinositol 3'-kinases promote mitotic cell death in HeLa cells.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Adenine; Androstadienes; Animals; Caspase 3; Cell Cycle Checkpoints; Cell Death; Cell Line; Cell Sur

2012
Tenofovir, COX inhibitors and zileuton during cancer immunotherapies: up-regulated TNF-alpha increases antigen driven lymphocyte proliferation.
    Molecular immunology, 2003, Volume: 40, Issue:5

    Topics: Adenine; Adenylyl Cyclases; Anti-HIV Agents; Cell Division; Cyclooxygenase Inhibitors; Humans; Hydro

2003
The liver nucleic acid incorporation of adenine-8-C14 during azo dye carcinogenesis.
    Cancer research, 1952, Volume: 12, Issue:10

    Topics: Adenine; Azo Compounds; Carcinogenesis; Liver; Neoplasms; Nucleic Acids; Organic Chemicals

1952
The effects of tumor growth, x-radiation, and 8-azaguanine on the incorporation of adenine into nucleic acids of mice.
    Cancer research, 1954, Volume: 14, Issue:11

    Topics: Adenine; Animals; Azaguanine; Guanine; Mice; Neoplasms; Nucleic Acids; Sarcoma; X-Rays

1954
Glycine and adenine as precursors of nucleic acid purines in tumor-bearing mice.
    The Journal of biological chemistry, 1955, Volume: 212, Issue:1

    Topics: Adenine; Animals; Glycine; Mice; Neoplasms; Nucleic Acids; Purines

1955
The effect of tumor fractions on the uptake of carbon-14-labeled adenine into the deoxyribonucleic acids of mouse tissues.
    Cancer research, 1955, Volume: 15, Issue:11

    Topics: Adenine; Animals; Carbon Radioisotopes; DNA; Mice; Neoplasms; Nucleic Acids

1955
Stimulation of adenine uptake into mouse lung and liver in vitro by tumor extracts.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1955, Volume: 90, Issue:1

    Topics: Adenine; Biochemical Phenomena; In Vitro Techniques; Liver; Lung; Neoplasms; Nucleic Acids

1955
[Effect of ribonuclease on the incorporation of adenine and phenylalanine in ascites cells in vitro].
    Archives internationales de physiologie et de biochimie, 1956, Volume: 64, Issue:1

    Topics: Adenine; Ascites; Biochemical Phenomena; DNA; Endonucleases; In Vitro Techniques; Neoplasms; Phenyla

1956
Autoradiograph studies with mouse Ehrlich ascites tumor.
    Annals of the New York Academy of Sciences, 1956, Mar-14, Volume: 63, Issue:5

    Topics: Adenine; Animals; Autoradiography; Biochemical Phenomena; Carcinoma, Ehrlich Tumor; Mice; Neoplasms;

1956
The effect of two purine analogs on a human tumor in tissue culture.
    Zeitschrift fur Krebsforschung, 1956, Volume: 61, Issue:4

    Topics: Adenine; Animals; Antimetabolites; Carcinoma; Carcinoma, Squamous Cell; Humans; Mercaptopurine; Neop

1956
The effect of two purine analogs on a human tumor in tissue culture.
    Zeitschrift fur Krebsforschung, 1956, Volume: 61, Issue:4

    Topics: Adenine; Animals; Antimetabolites; Carcinoma; Carcinoma, Squamous Cell; Humans; Mercaptopurine; Neop

1956
The effect of two purine analogs on a human tumor in tissue culture.
    Zeitschrift fur Krebsforschung, 1956, Volume: 61, Issue:4

    Topics: Adenine; Animals; Antimetabolites; Carcinoma; Carcinoma, Squamous Cell; Humans; Mercaptopurine; Neop

1956
The effect of two purine analogs on a human tumor in tissue culture.
    Zeitschrift fur Krebsforschung, 1956, Volume: 61, Issue:4

    Topics: Adenine; Animals; Antimetabolites; Carcinoma; Carcinoma, Squamous Cell; Humans; Mercaptopurine; Neop

1956
Induced changes in the nucleic acid and nucleotide content of various mouse tissues.
    Cancer research, 1957, Volume: 17, Issue:2

    Topics: Adenine; Animals; Antineoplastic Agents; Folic Acid Antagonists; Mice; Neoplasms; Nucleic Acids; Nuc

1957
Studies of the mechanism of action of urethane in initiating pulmonary adenomas in mice. II. Its relation to nucleic acid synthesis.
    The Journal of experimental medicine, 1957, Apr-01, Volume: 105, Issue:4

    Topics: Adenine; Adenoma; Animals; DNA; Lung Neoplasms; Mice; Neoplasms; Nucleic Acids; Orotic Acid; Pyrimid

1957
[Cortisone and adenine as protective drugs for leukocytes in deacetyl-colchicine cytostatic therapy].
    Minerva medica, 1957, Jan-06, Volume: 48, Issue:1-2

    Topics: Adenine; Colchicine; Cortisone; Humans; Leukocytes; Neoplasms; Protective Agents

1957
Early utilization of adenine and formate by mouse ascites tumor cells in vivo.
    Biochimica et biophysica acta, 1958, Volume: 30, Issue:2

    Topics: Adenine; Animals; Ascites; Biochemical Phenomena; Diploidy; Formates; Mice; Neoplasms

1958
Effects of 4-aminopyrazolo (3,4-d)pyrimidine and 1-methyl-4-aminopyrazolo(3,4-d)pyrimidine on nucleic acid purine metabolism in ascites tumors.
    Cancer research, 1961, Volume: 21

    Topics: Adenine; Ascites; Neoplasms; Nucleic Acids; Purines; Pyrimidines

1961
The metabolism of 4-aminopyrazolo(3,4-d)pyrimidine in normal and neoplastic tissues.
    Cancer research, 1961, Volume: 21

    Topics: Adenine; Neoplasms; Pyrimidines

1961
Adenine nucleotide breakdown and its relationship to polynucleotide phosphorylase in the crown-gall tumor inducing organism Agrobacterium tumefaciens.
    Canadian journal of biochemistry and physiology, 1961, Volume: 39

    Topics: Adenine; Adenine Nucleotides; Agrobacterium; Agrobacterium tumefaciens; Crowns; Neoplasms; Nucleotid

1961
[On the determination of the vitality of organ and tumor cultures by incorporation of marked adenine].
    Zeitschrift fur die gesamte experimentelle Medizin, 1961, Volume: 134

    Topics: Adenine; Animals; Neoplasms; Neoplasms, Experimental; Tissue Culture Techniques

1961
Permeability of Ehrlich ascites cells to adenine.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1960, Volume: 105

    Topics: Adenine; Ascites; Biochemical Phenomena; Neoplasms; Permeability; Tissue Culture Techniques

1960
STUDIES OF COMPOUNDS THAT INHIBIT CELL GROWTH.
    Experimental cell research, 1963, Volume: 24

    Topics: Acridines; Adenine; Animals; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; DNA, Neoplasm; Guanine; Liver

1963
PHYSIOLOGICAL DISPOSITION AND THERAPEUTIC CONSEQUENCES OF ADENINE ADMINISTERED VIA THE GASTROINTESTINAL TRACT IN NORMAL AND TUMOR-BEARING MICE.
    Cancer research, 1963, Volume: 23

    Topics: Adenine; Adenine Nucleotides; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatoc

1963
RNA AND DNA METABOLISM IN LIVER CELLS OF NORMAL AND CANCER-BEARING MICE.
    Experientia, 1963, Nov-15, Volume: 19

    Topics: Adenine; Animals; Autoradiography; DNA; Hepatocytes; Liver; Mammary Neoplasms, Animal; Mammary Neopl

1963
FRACTIONS WITH DIFFERING BASE COMPOSITION IN RNA FROM MALIGNANT CELLS OF MOUSE.
    Journal of molecular biology, 1963, Volume: 7

    Topics: Adenine; Animals; Autoradiography; Base Composition; Cytosine; Electrophoresis; Guanine; Mice; Neopl

1963
THE CHEMOTHERAPY OF CANCER WITH MASSIVE DOSES UNDER THE PROTECTION OF PERFUSION OF AUTOGENOUS HEMATOPOIETIC TISSUE.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Adenine; Bone Marrow Transplantation; Breast Neoplasms; DNA; Female; Folic Acid; Humans; Lung Neopla

1964
CONCENTRATIONS AND RATES OF SYNTHESIS OF NICOTINAMIDE-ADENINE-DINUCLEODIDE PHOSPHATE IN PRECANCEROUS LIVERS AND HEPATOMAS INDUCED BY AZO-DYE FEEDING.
    Nature, 1964, Mar-14, Volume: 201

    Topics: Adenine; Carcinogens; Carcinoma, Hepatocellular; Liver; Liver Neoplasms; NADP; Neoplasms; Neoplasms,

1964
[INCORPORATION OF FORMATE-C14 IN THE BASES OF THE NUCLEIC ACIDS OF STICKER'S TUMOR IN VIVO AND IN VITRO].
    Bollettino della Societa italiana di biologia sperimentale, 1963, Dec-31, Volume: 39

    Topics: Adenine; Aspartic Acid; Carbon Isotopes; DNA; DNA, Neoplasm; Dogs; Formates; Glucose; Glutamine; In

1963
INHIBITION OF DNA SYNTHESIS IN MAMMALIAN CELLS BY ACTIDIONE.
    Biochimica et biophysica acta, 1964, May-18, Volume: 87

    Topics: Adenine; Adenine Nucleotides; Anti-Bacterial Agents; Aspartic Acid; Carbon Isotopes; Carcinoma, Squa

1964
RADIOAUTOGRAPHIC EVALUATION OF FREEZE-THAW BUFFERS USING NUCLEIC ACID- AND GLYCINE-RELATED SYNTHETIC SYSTEMS IN VITRO.
    Laboratory investigation; a journal of technical methods and pathology, 1964, Volume: 13

    Topics: Adenine; Autoradiography; Buffers; Dextrans; Dimethyl Sulfoxide; Glycerol; Glycine; In Vitro Techniq

1964
TERATOGENESIS: EFFECTS OF SUBSTITUTED PURINES AND THE INFLUENCE OF 4-HYDROXYPYRAZOLOPYRIMIDINE IN THE RAT.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1964, Volume: 116

    Topics: Abnormalities, Drug-Induced; Adenine; Female; Mercaptopurine; Neoplasms; Neoplasms, Experimental; Ph

1964
METABOLISM OF PURINE NUCLEOSIDE ANALOGS.
    Cancer research, 1965, Volume: 25

    Topics: Adenine; Animals; Antimetabolites; Guanine; Mercaptopurine; Metabolism; Mice; Neoplasms; Neoplasms,

1965
SPECIFICITY OF DNA FROM NEOPLASTIC TISSUES IN VIVO AND IN VITRO.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Adenine; Animals; Carbon Isotopes; Cytosine; DNA; DNA, Neoplasm; Formates; Guanine; Histocytochemist

1964
ON THE OXIDATIVE PHOSPHORYLATION AND NUCLEIC ACIDS METABOLISM IN SOME ORGANS OF ANIMALS WITH TRANSPLANTABLE TUMOURS.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Adenine; Carbohydrate Metabolism; Cytosine; DNA; DNA, Neoplasm; Glycolysis; Guanine; Intestines; Kid

1964
THE EFFECTS OF 3'-DEOXYADENOSINE ON THE SYNTHESIS OF RIBONUCLEIC ACID.
    The Journal of biological chemistry, 1965, Volume: 240

    Topics: Adenine; Adenosine Triphosphate; Antimetabolites; Antineoplastic Agents; Carbon Isotopes; Carcinoma,

1965
METABOLIC EFFECTS OF AN ANTIBIOTIC, NSC-51954, ON SUSCEPTIBLE AND RESISTANT TUMOR CELLS.
    Cancer research, 1965, Volume: 25

    Topics: Adenine; Animals; Anti-Bacterial Agents; Carbon Isotopes; Carcinoma, Ehrlich Tumor; DNA; DNA, Neopla

1965
THE EFFECT OF BETA-XYLOSYL ADENINE ON THE FORMATION OF 5-PHOSPHORIBOSYL-1-PYROPHOSPHATE BY CELL-FREE EXTRACTS OF TA3 ASCITES CELLS.
    Canadian journal of biochemistry, 1965, Volume: 43

    Topics: Adenine; Adenosine Triphosphate; Animals; Antimetabolites; Ascites; Carbon Isotopes; Diphosphates; M

1965
BASE COMPOSITION OF HIGH MOLECULAR WEIGHT NUCLEAR RNA OF WALKER TUMOR AND LIVER OF THE RAT.
    Cancer research, 1965, Volume: 25

    Topics: Adenine; Adenine Nucleotides; Animals; Base Composition; Carcinoma 256, Walker; Cytosine; Cytosine N

1965
Stimulation of tumorous aggregations in Drosophila by addition of indoleacetic acid and adenine to culture medium.
    Growth, 1955, Volume: 19, Issue:1

    Topics: Adenine; Animals; Culture Media; Drosophila; Indoleacetic Acids; Neoplasms; Neoplasms, Experimental

1955
On the effect of some adenine derivatives on the incorporation in vitro of isotopically labelled compounds into the nucleic acids of Ehrlich ascites tumor cells.
    Biochimica et biophysica acta, 1959, Volume: 35

    Topics: Adenine; Animals; Biochemical Phenomena; Carcinoma, Ehrlich Tumor; Formates; In Vitro Techniques; Ne

1959
Targeting wide-range oncogenic transformation via PU24FCl, a specific inhibitor of tumor Hsp90.
    Chemistry & biology, 2004, Volume: 11, Issue:6

    Topics: Adenine; Animals; Anisoles; Antineoplastic Agents; Cell Division; Cell Line; Cell Line, Tumor; Cell

2004
Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells.
    International journal of biological macromolecules, 2004, Volume: 34, Issue:4

    Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans;

2004
The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: reactivation of carbon dioxide-treated homogenates by riboflavin-adenine dinucleotide.
    The Journal of biological chemistry, 1950, Volume: 185, Issue:1

    Topics: Adenine; Azo Compounds; Carbon Dioxide; Flavin-Adenine Dinucleotide; Liver; Neoplasms; p-Dimethylami

1950
DNA minor groove adducts formed by a platinum-acridine conjugate inhibit association of tata-binding protein with its cognate sequence.
    Biochemistry, 2005, Aug-23, Volume: 44, Issue:33

    Topics: Acridines; Adenine; Animals; Antineoplastic Agents; Binding Sites; DNA Adducts; Humans; Neoplasms; N

2005
Synthesis and biological activity of 2-fluoro adenine and 6-methyl purine nucleoside analogs as prodrugs for suicide gene therapy of cancer.
    Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:5-7

    Topics: Adenine; Antineoplastic Agents; Carbon; Escherichia coli; Genetic Therapy; Humans; Models, Chemical;

2005
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Chemical biology & drug design, 2006, Volume: 67, Issue:1

    Topics: Adenine; Adenosine Triphosphate; Bone and Bones; Carbon; Catalytic Domain; Cyclin-Dependent Kinase 2

2006
Antitumor activity of sequence-specific alkylating agents: pyrolle-imidazole CBI conjugates with indole linker.
    Cancer science, 2006, Volume: 97, Issue:3

    Topics: Adenine; Alkylation; Animals; Antineoplastic Agents, Alkylating; Base Sequence; Cell Line, Tumor; Cy

2006
Formation of depurinating N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or enzyme-activated 1,2-dihydroxynaphthalene with DNA. Implications for the mechanism of tumor initiation by naphthalene.
    Chemico-biological interactions, 2007, Feb-20, Volume: 165, Issue:3

    Topics: Adenine; Carcinogens; DNA Adducts; Guanine; Kinetics; Molecular Structure; Naphthalenes; Naphthols;

2007
A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Biochimie, 2007, Volume: 89, Issue:10

    Topics: Adenine; Animals; Base Sequence; Catalysis; Humans; Hydrogen-Ion Concentration; Magnesium; MAP Kinas

2007
The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells.
    The Journal of biological chemistry, 2007, Dec-21, Volume: 282, Issue:51

    Topics: Adenine; Animals; Antibiotics, Antineoplastic; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; H

2007
Evidence of complete cellular repair of 1,N6-ethenoadenine, a mutagenic and potential damage for human cancer, revealed by a novel method.
    Molecular and cellular biochemistry, 2008, Volume: 313, Issue:1-2

    Topics: Adenine; Animals; Biological Assay; Cell Cycle; Cell Extracts; DNA; DNA Damage; DNA Repair; HCT116 C

2008
Transport of folate compounds, pterins and adenine in L1210 mouse leukemia cells.
    Advances in enzyme regulation, 1982, Volume: 20

    Topics: Adenine; Animals; Biological Transport; Energy Metabolism; Folic Acid; Leukemia L1210; Membranes; Me

1982
ATM mutations in cancer families.
    Cancer research, 1996, Sep-15, Volume: 56, Issue:18

    Topics: Adenine; Alleles; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Breast Neoplasms; C

1996
Mechanistic study on the cytostatic and tumor cell differentiation-inducing properties of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, adefovir)-collected publications.
    Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie, 2000, Volume: 62, Issue:5

    Topics: Adenine; Animals; Antineoplastic Agents; Antiviral Agents; Cell Differentiation; Cell Division; Cell

2000
Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.
    Anti-cancer drugs, 2001, Volume: 12, Issue:3

    Topics: Adenine; Animals; Antineoplastic Agents; Colony-Forming Units Assay; Dose-Response Relationship, Dru

2001
Cancer procoagulant and blood platelet activation.
    Cancer letters, 2001, Aug-28, Volume: 169, Issue:2

    Topics: Adenine; Animals; Blood Platelets; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Neopla

2001
Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days.
    Bone marrow transplantation, 2001, Volume: 28, Issue:2

    Topics: Adenine; Antigens, CD; Antigens, CD34; Blood Preservation; Breast Neoplasms; Cell Culture Techniques

2001
Determination of trimethylsilyl methylated nucleic acid bases in urine by gas-liquid chromatography.
    Journal of chromatography, 1976, Jan-07, Volume: 116, Issue:1

    Topics: Adenine; Adsorption; Chromatography, Gas; Guanine; Humans; Hydrogen-Ion Concentration; Hydrolysis; M

1976
High-resolution liquid chromatographic analysis of methylated purine and pyrimidine bases in transfer RNA.
    Journal of chromatography, 1976, Jan-07, Volume: 116, Issue:1

    Topics: Adenine; Animals; Cattle; Chemical Phenomena; Chemistry; Chromatography, Liquid; Cytosine; Guanine;

1976
[Analysis of normal and methylated urinary nucleobases: a new criterion for diagnosis and follow-up of malignancies (author's transl)].
    Klinische Padiatrie, 1979, Volume: 191, Issue:2

    Topics: Adenine; Adolescent; Adult; Child; Child, Preschool; Creatinine; Guanine; Humans; Infant; Neoplasms;

1979
New potential cytotoxic and antitumor substances I. In vitro effect of bikaverin and its derivatives on cells of certain tumors.
    Neoplasma, 1975, Volume: 22, Issue:3

    Topics: Adenine; Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; DNA, Neoplasm; In Vitro Techniques; Leu

1975
Disturbance in the metabolism of 5'-methylthioadenosine and adenine in patients with neoplastic diseases, and in those with a deficiency in adenine phosphoribosyltransferase.
    Metabolism: clinical and experimental, 1991, Volume: 40, Issue:9

    Topics: Adenine; Adenine Phosphoribosyltransferase; Adenosine; Adult; Aged; Deoxyadenosines; Female; Humans;

1991
Flexibility of nucleic acid bases and its possible relationship with carcinogenesis.
    Progress in clinical and biological research, 1985, Volume: 172B

    Topics: Adenine; Animals; Cytosine; DNA; Guanine; Humans; Hydrogen Bonding; Neoplasms; Nucleic Acid Conforma

1985
Studies on the mechanism of cytotoxicity of 3-deazaguanosine in human cancer cells.
    Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:1

    Topics: Adenine; Cell Division; Cells, Cultured; DNA; Formates; GMP Reductase; Guanine; Guanosine; Humans; N

1985
[The genetic effect of aromatic amines and their derivatives: induction of mytotic conversion in the yeast Saccharomyces cerevisiae].
    Zeitschrift fur Krebsforschung, 1970, Volume: 74, Issue:4

    Topics: Adenine; Amines; Carcinogens; Chemical Phenomena; Chemistry; Culture Media; Fluorenes; Genes; Geneti

1970
Purine N-oxides. XIX. On the oncogenic N-oxide derivatives of guanine and xanthine and a nononcogenic isomer of xanthine N-oxide.
    Cancer research, 1967, Volume: 27, Issue:5

    Topics: Adenine; Animals; Carcinoma, Hepatocellular; Guanine; Liver Neoplasms; Mercaptopurine; Neoplasms; Ne

1967
Inhibitors of nucleoside and nucleotide metabolism.
    Cancer chemotherapy reports. Part 2, 1972, Volume: 3, Issue:1

    Topics: Adenine; Adenine Nucleotides; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Erythrocytes; Guan

1972
Drugs used in radiotherapy.
    Radiography, 1972, Volume: 38, Issue:448

    Topics: Adenine; Alkylating Agents; Analgesics; Anemia; Anti-Bacterial Agents; Antiemetics; Antimetabolites;

1972
7-methylguanine and other minor urinary purines: values for normal subjects from Israel, Gaza, and Kenya, and for patients with cancer of various organs or cirrhosis of the liver.
    Cancer, 1971, Volume: 27, Issue:3

    Topics: Adenine; Adult; Aged; Arabia; Child; Creatinine; Female; Humans; Hypoxanthines; Israel; Kenya; Liver

1971
Some aspects of the role of vitamin B 12 and folic acid in DNA-thymidine sy nthesis in a neoplastic C3H mouse cell strain.
    Journal of the National Cancer Institute, 1971, Volume: 47, Issue:2

    Topics: Adenine; Animals; Carbon Isotopes; Cell Line; Chromatography, Paper; Culture Media; Culture Techniqu

1971
Effects of nitrogen mustard and cyclophosphamide upon the synthesis of DNA in vivo and in cell-free preparations.
    Cancer research, 1969, Volume: 29, Issue:1

    Topics: Adenine; Animals; Carbon Isotopes; Cell-Free System; Cricetinae; Cyclophosphamide; Depression, Chemi

1969